Prospects and progress for Bacillus thuringiensis‐based pesticides

Author:

Abstract
Bacillus thuringiensis (Bt)‐based insecticide products constitute the overwhelming majority of biopesticides but, despite having been commercially available for over 30 years, they have made little impact (<1%) on the crop‐protection market as a whole. This has been largely due to poor cost‐performance factors relative to synthetic organic pesticides. However, recent biotechnological advances—including genetic modification—combined with a variety of emerging opportunities, have created the prospect of the commercialisation of a new range of highly effective Bt‐based biopesticides.Bioencapsulation of single‐gene products—delta‐endotoxins from selected Bt isolates—in killed Pseudomonad cells (Mycogen Corporation's ‘CellCap’ technology), offers a flexible delivery system with enhanced persistence.This versatile approach selects only the most appropriate biotoxins, which can be used to target a number of pest species. It is anticipated that Bt‐based pesticides will continue to fill an increasing number of gaps in the panoply of synthetic crop‐protection chemicals. Genetically modified products offer advantages in terms of efficacy, flexibility and safety but public concerns regarding perceived risks need to be addressed.

This publication has 23 references indexed in Scilit: